Status:
COMPLETED
The Role of Adverse Environment Factors, Family Functioning and Parental Psychopathology in the Response to Treatment With Methylphenidate in Children and Adolescents With Attention Deficit/Hyperactivity Disorder
Lead Sponsor:
Federal University of Rio Grande do Sul
Collaborating Sponsors:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Hospital de Clinicas de Porto Alegre
Conditions:
Attention Deficit Disorder With Hyperactivity
Eligibility:
All Genders
5-18 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to investigate the association of adverse environmental factors, parental psychopathology, family functioning and genetic factors and the response to methylphenidate treat...
Detailed Description
Attention Deficit/Hyperactivity Disorder (ADHD) is a chronic disorder, with a worldwide estimated prevalence of 5,29%. It is associated with a high risk of functional impairment in many aspects of the...
Eligibility Criteria
Inclusion
- ADHD
- Age: 5 - 18
- Primary Indication of Methylphenidate
Exclusion
- IQ \< 70
- Clinical conditions that preclude use of methylphenidate
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT00773916
Start Date
March 1 2006
End Date
July 1 2009
Last Update
August 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ADHD Outpatient Program - Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-903